NPI Details
DR. Steven Elliott Call, M.D. is an internal medicine in Springville, UT with 23 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Steven Elliott Call, M.D. NPI is 1619091063. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2003
The provider's business location address is:
771 W 450 S
STE B
SPRINGVILLE, UT
ZIP 84663-222
Phone: (801) 226-0737
Fax: (801) 226-0832
The NPI 1619091063 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, tocilizumab, 1 mg (HCPCS:J3262)
- Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
- Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
- Complete ultrasound scan of joint (HCPCS:76881)
- Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Injection, zoledronic acid, 1 mg (HCPCS:J3489)
- Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
- Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
- Aspiration and/or injection of fluid from large joint (HCPCS:20610)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Aspiration and/or injection of fluid from small joint using ultrasound guidance (HCPCS:20604)
The enumeration date for this NPI number is 3/19/2007 and was last updated on 1/26/2016.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 5761120-1205 | UTAH | Yes |
